Literature DB >> 6439040

Arteriohepatic dysplasia (Alagille syndrome): extreme variability among affected family members.

S A Shulman, J S Hyams, R Gunta, R M Greenstein, S B Cassidy.   

Abstract

We describe a three-generation family in which five individuals have arteriohepatic dysplasia (Alagille syndrome) with striking differences in the degree of severity. Two sisters presented with neonatal jaundice, peripheral pulmonic stenosis, and characteristic facial appearance including a broad forehead, deep-set eyes, prominent nose, and pointed chin. One died at 5 years of cirrhosis with portal hypertension and the other at 18 months of congestive heart failure. Their asymptomatic 32-year-old mother and 35-year-old maternal aunt have a similar facial appearance, pulmonic stenosis, skeletal anomalies, and bilateral posterior embryotoxon. Neither has evidence of clinical liver disease. The maternal grandfather, who refused evaluation, has a similar appearance, a history of liver disease, and a heart murmur. Extreme intrafamilial variability has not been reported previously and most affected individuals described in the past have followed a benign course. The pattern of severity in this family suggests the possibility of a maternal factor augmenting the clinical expression in affected offspring. The skeletal anomalies and posterior embryotoxon are valuable signs in detecting asymptomatic but affected individuals who are at risk for having offspring with this potentially lethal condition.

Entities:  

Mesh:

Year:  1984        PMID: 6439040     DOI: 10.1002/ajmg.1320190215

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  17 in total

Review 1.  Alagille syndrome and deletion of 20p.

Authors:  F Anad; J Burn; D Matthews; I Cross; B C Davison; R Mueller; M Sands; D M Lillington; E Eastham
Journal:  J Med Genet       Date:  1990-12       Impact factor: 6.318

2.  Alagille syndrome and optic pit.

Authors:  Antonio Fea; Andrea Grosso; Marilena Rabbione; Federico Grignolo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-02       Impact factor: 3.117

3.  Spectrum and frequency of jagged1 (JAG1) mutations in Alagille syndrome patients and their families.

Authors:  I D Krantz; R P Colliton; A Genin; E B Rand; L Li; D A Piccoli; N B Spinner
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

4.  Alagille syndrome: family studies.

Authors:  F V Elmslie; A J Vivian; H Gardiner; C Hall; A P Mowat; R M Winter
Journal:  J Med Genet       Date:  1995-04       Impact factor: 6.318

Review 5.  Alagille syndrome.

Authors:  I D Krantz; D A Piccoli; N B Spinner
Journal:  J Med Genet       Date:  1997-02       Impact factor: 6.318

6.  Molecular analysis of 24 Alagille syndrome families identifies a single submicroscopic deletion and further localizes the Alagille region within 20p12.

Authors:  E B Rand; N B Spinner; D A Piccoli; P F Whitington; R Taub
Journal:  Am J Hum Genet       Date:  1995-11       Impact factor: 11.025

7.  Segregation analysis of Alagille syndrome.

Authors:  S Dhorne-Pollet; J F Deleuze; M Hadchouel; C Bonaïti-Pellié
Journal:  J Med Genet       Date:  1994-06       Impact factor: 6.318

8.  Deleted chromosome 20 from a patient with Alagille syndrome isolated in a cell hybrid through leucine transport selection: study of three candidate genes.

Authors:  J F Deleuze; S Dhorne; J Hazan; E Borghi; N Raynaud; N Pollet; M Meunier-Rotival; J Deschatrette; D Alagille; M Hadchouel
Journal:  Mamm Genome       Date:  1994-11       Impact factor: 2.957

9.  Conditional JAG1 mutation shows the developing heart is more sensitive than developing liver to JAG1 dosage.

Authors:  Fengmin Lu; Jennifer J D Morrissette; Nancy B Spinner
Journal:  Am J Hum Genet       Date:  2003-03-14       Impact factor: 11.025

10.  Cytologically balanced t(2;20) in a two-generation family with alagille syndrome: cytogenetic and molecular studies.

Authors:  N B Spinner; E B Rand; P Fortina; A Genin; R Taub; A Semeraro; D A Piccoli
Journal:  Am J Hum Genet       Date:  1994-08       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.